TP53 and neoplasm: Bioinformatic analysis suggested that 11 genes may contribute to the anti‐tumour effects of hesperidin, including AURKB, BCL6, CASP3, CD80, ghrelin, G6PD, HMOX1, IRF‐7, MMP9, TP53 and (SP1).48